评估百因止治疗中国非经治中重度甲型血友病患者的安全性和耐受性的回顾性病历收集研究
[Translation] A retrospective medical record-collection study to assess the safety and tolerability of Promethazine for the treatment of moderate-to-severe hemophilia A in Chinese non-pretreated patients
评估百因止治疗中国非经治中重度甲型血友病患者的安全性和耐受性,包括抑制物的形成,以及其他严重的和非严重的不良事件。
[Translation] To evaluate the safety and tolerability, including formation of inhibitors, and other serious and non-serious adverse events in Chinese untreated patients with moderate-to-severe hemophilia A.
评估百因止治疗既往接受过治疗的甲型血友病患者的疗效和安全性的研究
[Translation] A study to evaluate the efficacy and safety of Promethazine in previously treated patients with hemophilia A
评估百因止用于治疗和预防出血事件(BE)的疗效、安全性和药代动力学
[Translation] To evaluate the efficacy, safety and pharmacokinetics of Promethazine for the treatment and prevention of bleeding events (BE)
100 Clinical Results associated with Baxter SA de CV
0 Patents (Medical) associated with Baxter SA de CV
100 Deals associated with Baxter SA de CV
100 Translational Medicine associated with Baxter SA de CV